11/13/2024
4:16 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:01 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
7:57 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
11:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B4 | |
10/29/2024
11:15 PM | Shuttle Pharmaceuticals (Filer)
| Form EFFECT | |
10/29/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:05 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/28/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
7:49 AM | Shuttle Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/25/2024
7:52 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
8:06 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1/A | |
10/17/2024
4:17 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:00 PM | Jung Mira (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
5:04 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/13/2024
7:25 PM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
09/13/2024
4:00 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
4:23 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
3:26 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
8:51 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-K/A | |
09/03/2024
8:52 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/03/2024
8:54 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/28/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
5:08 AM | Shuttle Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/07/2024
7:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
8:45 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
3:59 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:42 PM | Lorber Timothy J. (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
5:12 AM | Shuttle Pharmaceuticals (Filer)
| Form PRE 14A | |
05/22/2024
3:15 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
4:01 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
9:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:36 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
4:06 PM | Shuttle Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/22/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
5:07 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
03/21/2024
4:28 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
4:02 PM | Senanayake Chris (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:18 PM | Shuttle Pharmaceuticals (Issuer)
Vander Hoek Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
When it comes to NVDA… “acceleration cycles” are the key (Ad) Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options…
By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)...
And thanks to many months and late nights working out the kinks of the systems…
They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! |
02/13/2024
7:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
4:10 PM | Brown Milton (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
8:51 PM | Jacobs Bette (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
